Kolexia
Vallee Alain
Psychiatrie
Cabinet libéral
Nantes, France
22 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Tumeurs du poumon Épanchement pleural {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

IMHEM - DÉCÈS du Docteur Alain VALLÉE Mes chers amis La... - Facebook
Facebook   24 novembre 2023
IMHEM - DÉCÈS du Docteur Alain VALLÉE Mes chers amis La... - Facebook
Facebook   17 novembre 2023
1359P Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1050P Association of ctDNA quantification with prognosis and early prediction of response to first-line osimertinib in NSCLC patients
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
1130P Anchored multiplex PCR-based targeted sequencing for the detection of fusion transcripts in FFPE samples of non-small cell lung cancer patients
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
1354P Detection of EGFR T790M in EGFR activating mutation-positive advanced non-small cell lung cancer (NSCLC): Comparison between two assays on circulating tumour (ct)DNA
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Nationwide external quality assessment (EQA) of EGFR testing in circulating tumor DNA: The French experience
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis
Abstracts of the 13th Congress of the European Association of Dermato‐Oncology (EADO), Athens, Greece, 3–6 May 2017   20 juin 2017
Profile response to Vemurafenib of melanoma patients with a BRAF D594N mutation
Abstracts of the 13th Congress of the European Association of Dermato‐Oncology (EADO), Athens, Greece, 3–6 May 2017   20 juin 2017
Détection de mutations de BRAF dans le plasma de patients atteints de mélanome métastatique
SI: Journées Dermatologiques de Paris 2015   01 décembre 2015